QTAS Information

At QTAS, we’re building a quantum-enabled liquid biopsy platform designed for pharma and translational research workflows. Our technology enables automated isolation of rare circulating tumor cells directly from whole blood—unlocking rapid, high-quality downstream analysis such as sequencing, molecular profiling, and functional assays. QTAS helps pharma teams generate earlier, more actionable insights to accelerate therapy development and optimization.